- Home
- GERN vs MPW Comparison
GERN vs MPW Comparison
Compare GERN & MPW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GERN
- MPW
- Stock Information
- Founded
- GERN 1990
- MPW 2003
- Country
- GERN United States
- MPW United States
- Employees
- GERN N/A
- MPW N/A
- Industry
- GERN Biotechnology: Pharmaceutical Preparations
- MPW Real Estate Investment Trusts
- Sector
- GERN Health Care
- MPW Real Estate
- Exchange
- GERN Nasdaq
- MPW Nasdaq
- Market Cap
- GERN 2.5B
- MPW 2.9B
- IPO Year
- GERN 1996
- MPW 2005
- Fundamental
- Price
- GERN $3.66
- MPW $4.31
- Analyst Decision
- GERN Strong Buy
- MPW Hold
- Analyst Count
- GERN 10
- MPW 9
- Target Price
- GERN $6.95
- MPW $5.38
- AVG Volume (30 Days)
- GERN 9.5M
- MPW 10.8M
- Earning Date
- GERN 11-07-2024
- MPW 11-07-2024
- Dividend Yield
- GERN N/A
- MPW 12.30%
- EPS Growth
- GERN N/A
- MPW N/A
- EPS
- GERN N/A
- MPW N/A
- Revenue
- GERN $29,480,000.00
- MPW $660,172,000.00
- Revenue This Year
- GERN $30,930.80
- MPW N/A
- Revenue Next Year
- GERN $315.72
- MPW N/A
- P/E Ratio
- GERN N/A
- MPW N/A
- Revenue Growth
- GERN 9199.68
- MPW N/A
- 52 Week Low
- GERN $1.64
- MPW $2.92
- 52 Week High
- GERN $5.34
- MPW $6.55
- Technical
- Relative Strength Index (RSI)
- GERN 29.99
- MPW 38.88
- Support Level
- GERN $3.98
- MPW $4.31
- Resistance Level
- GERN $4.50
- MPW $4.99
- Average True Range (ATR)
- GERN 0.21
- MPW 0.22
- MACD
- GERN -0.05
- MPW -0.01
- Stochastic Oscillator
- GERN 3.45
- MPW 17.07
About GERN Geron Corporation
Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.
About MPW Medical Properties Trust Inc. common stock
Medical Properties Trust Inc is a healthcare facility REIT. The company operates one segment, which owns and leases healthcare facilities. The vast majority of Medical's revenue is generated in the United States, followed by Germany and the United Kingdom. It provides financing for a variety of facilities that require funds for acquisitions, sale-leasebacks, new developments, and expansion projects.